Protein phosphatase 2A as therapeutic targets in various disease models

Area of Science:

• Cellular Biology
• Molecular Signaling
• Biochemistry

Background:

• Cellular signaling relies on complex pathways, with protein kinases and phosphatases playing critical roles.
• Protein phosphatases, particularly Protein Phosphatase 2A (PP2A), are essential for dephosphorylating signaling proteins, thus regulating signal transduction.
• PP2A is a highly conserved serine/threonine phosphatase involved in diverse cellular processes, including cell cycle regulation and morphology.

Purpose of the Study:

• To review the structure and regulatory pathways of Protein Phosphatase 2A (PP2A).
• To highlight the significant therapeutic potential of PP2A due to its critical role in cellular signaling.
• To discuss the involvement of PP2A dysregulation in diseases such as cancer, heart disease, neurodegenerative disorders, and diabetes.

Main Methods:

• Literature review focusing on the structure and regulation of PP2A.
• Analysis of PP2A's substrate specificities and involvement in signaling modules.
• Examination of PP2A's role in various pathological conditions.

Main Results:

• PP2A is a ubiquitously expressed, conserved enzyme with a complex structure involving catalytic and regulatory subunits.
• Its activity is tightly regulated, impacting numerous cellular processes and signaling pathways.
• PP2A dysregulation is implicated in the pathogenesis of major diseases, including malignancies and neurodegenerative disorders.

Conclusions:

• Protein Phosphatase 2A (PP2A) is a vital regulator of cellular signaling with significant therapeutic implications.
• Understanding PP2A's structure, regulation, and role in disease is crucial for developing novel therapeutic strategies.
• Further research into PP2A's untapped therapeutic potential is warranted for treating various pathologies.